Alvogen agrees biosimilar commercial deals in three major markets 23-Oct-2019 By Staff Reporter Biosimilar developer agrees three different distribution partners in South Korea, Israel and Canada for biosimilar to Forteo.
Alvotech and Cipla partner on Humira biosimilar 06-Aug-2019 By Vassia Barba Alvotech and Cipla agree to jointly commercialize another biosimilar to AbbVie's Humira, ahead of filing with the US FDA and the EMA.
Alvotech provides Stelara biosimilar supply to Fuji Pharma 17-Apr-2019 By Ben Hargreaves Fuji Pharma signs agreement to receive an exclusive supply of the ustekinumab biosimilar for the Japanese market, furthering a previous investment agreement.
